Boc-DL-Tyr(Me)-OH

Boc-DL-Tyr(Me)-OH is a Boc-protected, DL-configured tyrosine derivative bearing a methyl-substituted phenolic side chain, designed for peptide-coupling workflows where the N-terminus is pre-protected and the aromatic functionality is masked to control side reactions. The combination of a Boc carbamate and a substituted tyrosine side chain makes this reagent a practical building block for constructing Tyr-containing peptide segments with reduced phenolic reactivity during assembly. Researchers commonly select this type of protected amino acid to improve coupling reliability and to manage chemoselectivity in multi-step peptide synthesis and intermediate preparation.

1. Peptide Segment Building

Boc-DL-Tyr(Me)-OH is used as a protected amino acid building block for preparing peptide segments that incorporate a substituted tyrosine residue, particularly in custom peptide synthesis and library workflows where N-terminal Boc protection supports controlled coupling and downstream handling. Peptide chemists rely on the pre-installed Boc group to keep the amino functionality protected during segment assembly, while the substituted aromatic side chain helps minimize unwanted side reactions associated with free phenolic groups. This reagent is especially relevant when tyrosine-derived positions must be introduced as part of larger sequences and the synthesis strategy benefits from a Boc-protected amino acid intermediate rather than a free amino acid.

2. Solution-Phase Coupling Intermediates

Boc-DL-Tyr(Me)-OH is frequently selected for solution-phase peptide synthesis and intermediate preparation steps where Boc-protected amino acid derivatives are used to build defined amide linkages under controlled conditions. Medicinal chemistry groups developing peptidomimetic scaffolds and peptide-like intermediates often prefer protected amino acids that reduce side-chain interference during coupling and purification. The DL stereochemical nature supports workflows that prioritize synthetic availability and defined residue incorporation at the target position, while the Boc group provides an amino-protection handle that fits common protected-amino-acid condensation strategies used in research-scale and process-development settings.

3. Peptide Library and SAR Workflows

Boc-DL-Tyr(Me)-OH supports peptide library construction and structure-activity relationship (SAR) studies that require systematic variation around aromatic residues derived from tyrosine. By supplying a protected tyrosine derivative with a masked aromatic functionality, this reagent helps maintain consistency across analogs during parallel synthesis, enabling downstream comparative evaluation of peptide properties without complications from phenolic reactivity during assembly. Researchers in chemical biology and medicinal chemistry use such protected amino acid building blocks to generate defined peptide analog sets where the aromatic residue is introduced in a controlled, synthesis-compatible form, streamlining the generation of sequence-defined intermediates for subsequent deprotection and functional diversification steps.

4. Pharmaceutical Intermediate Development

Boc-DL-Tyr(Me)-OH is also used as a protected amino acid intermediate in the development of peptide-based pharmaceutical intermediates and related specialty chemical targets that require tyrosine-derived fragments. Process development teams and contract synthesis groups value Boc-protected amino acid derivatives because they can be handled as stable, isolable intermediates and incorporated into larger synthetic sequences with predictable protection-state management. The substituted tyrosine side chain further supports chemoselective assembly strategies by limiting side-chain reactivity during intermediate formation, which can be important when scaling peptide fragment synthesis or preparing defined building blocks for subsequent coupling and purification steps.

1. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

2. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

3. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

4. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance

5. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die